Press Release

FOR IMMEDIATE RELEASE 

Apothecary Ink announces pain-reducing tattoo formula 

Albuquerque, New Mexico – September 1st, 2021

Apothecary Ink is excited to announce a non-toxic tattoo ink formulation that reduces the pain and inflammation associated with tattoos. 

Designed by a talented team of medical professionals whose specialties include pain management, Apothecary Ink does not contain lidocaine, lignocaine, tetracaine, benzocaine, proparacaine, or any other voltage-dependent sodium channel inhibitors and is composed of pharmaceutical ingredients commonly purchased over the counter. The patent-pending formula is ideal for analgesia or reducing pain, discomfort, swelling, irritation, and bleeding in various dermatologic applications. Apothecary Ink does not require special training or education to use.

About Apothecary Ink

Apothecary Ink, LLC is made up of a talented team of medical professionals and entrepreneurs. Apothecary Ink was founded by Dr. David Arnold, who holds a BS in pharmaceutical sciences, an MBA, and a Doctorate in Pharmacy from the University of New Mexico. He started in the medical field working EMS in Los Angeles and used his skills to train others while in the Marines. He deployed once with the Marines and started college immediately after returning from overseas. He has been a licensed pharmacist for two years and is also a licensed pharmacist clinician and a pharmacy preceptor in New Mexico. 

For more information, see apothink.com or email info@apothink.com. 

Apothecary Ink is owned by Apothecary Ink LLC, a New Mexico limited liability company. Apothecary Ink LLC is a Veteran Affiliated and female-owned company.  Utility Patent Application 35 USC 111(a) # 17399000. INK FORMULATION AND MANUFACTURE THEREOF. Filed August 10th, 2021.